bioAffinity Technologies, Inc.

The momentum for this stock is not very good. bioAffinity Technologies, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in bioAffinity Technologies, Inc..

News

BioAffinity Technologies files to sell 1.8M shares of common stock for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Analyzing bioAffinity Technologies (NASDAQ:BIAF) and DNAPrint Genomics (OTCMKTS:DNAG)

Ticker Report DNAPrint Genomics (OTCMKTS:DNAG - Get Free Report) and bioAffinity Technologies (NASDAQ:BIAF - Get Free Report) are both medical companies, but which is the better investment? We will compare the two...\n more…

bioAffinity Technologies CFO Michael Dougherty to depart

SeekingAlpha.com: All News bioAffinity Technologies CFO resigns, interim CFO appointed. Stock up +2.72% after hours.\n more…

BioAffinity Technologies CFO Michael Dougherty resigns

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO

Business Wire bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that Michael Dougherty...\n more…

Maxim Group Remains a Buy on bioAffinity Technologies, Inc. (BIAF)

TipRanks Financial Blog Maxim Group analyst Anthony Vendetti reiterated a Buy rating on bioAffinity Technologies, Inc. (BIAF - Research Report) yesterday. The company's sh...\n more…